机构风向标 | 悦康药业(688658)2025年三季度已披露前十大机构持股比例合计下跌4.89个百分点

Group 1 - Yuyuan Pharmaceutical (688658.SH) reported its Q3 2025 results, with 27 institutional investors holding a total of 262 million shares, representing 58.19% of the company's total equity as of October 29, 2025 [1] - The top ten institutional investors collectively hold 53.65% of the shares, with a decrease of 4.89 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 12 funds increased their holdings, accounting for 3.94% of the total, including notable funds such as Fuqun Medical Innovation Stock A and E Fund Healthcare Industry Mixed A [2] - Two public funds decreased their holdings, representing a reduction of 0.26%, including China Merchants Medical Health Industry Stock and Fuqun Precision Medical Flexible Allocation Mixed A [2] - Six new public funds were disclosed this period, while 160 funds were not disclosed compared to the previous quarter, indicating significant changes in the public fund landscape [2]